Catalyst Wire Dossier Catalyst Wire Dossier

valganciclovir syrup

valganciclovir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for valganciclovir syrup, covering 2015-12-17 to 2015-12-17. Get the full timeline:

Most recent: Clinical Trial Update: WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients [Phase 3]

See pricing